Lingbin Meng (@lingbin_meng) 's Twitter Profile
Lingbin Meng

@lingbin_meng

MD, PhD; Assistant Professor; Genitourinary Oncologist at The Ohio State University Wexner Medical Center

ID: 1524807731307216896

calendar_today12-05-2022 17:44:41

14 Tweet

99 Followers

94 Following

Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

Association of Age With Adverse Events and Survival in Patients With Metastatic Colorectal Cancer jamanetwork.com/journals/jaman…

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

New research from Lingbin Meng & colleagues: Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer JAMA Network Open The James jamanetwork.com/journals/jaman…

New research from <a href="/lingbin_meng/">Lingbin Meng</a> &amp; colleagues:  Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal Cancer <a href="/JAMANetworkOpen/">JAMA Network Open</a> <a href="/OSUCCC_James/">The James</a> 
jamanetwork.com/journals/jaman…
Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

New publication from #GU #MedOnc team & colleagues: Emerging Immunotherapy Approaches for Treating Prostate Cancer mdpi.com/2487952 #mdpiijms via IJMS MDPI Lingbin Meng #YuanquanYang #AmirMortazavi

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

New publication from Lingbin Meng & colleagues: Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis dx.doi.org/10.7150/jca.87…

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

The James GU oncologist Lingbin Meng presenting her research on improving survival in metastatic neuroendocrine bladder cancer: the transformative impact of immunochemotherapy at ASCO GU ASCO

<a href="/OSUCCC_James/">The James</a> GU oncologist <a href="/lingbin_meng/">Lingbin Meng</a> presenting her research on improving survival in metastatic neuroendocrine bladder cancer: the transformative impact of immunochemotherapy at ASCO GU <a href="/ASCO/">ASCO</a>
Pelotonia Institute for Immuno-Oncology (@ohiostatepiio) 's Twitter Profile Photo

🔬 New review from Ohio State Medical Oncology & Pelotonia Institute for Immuno-Oncology researchers explores #CNPY2 in #SolidTumors—its mechanisms, #biomarker potential, & #therapeutic implications. Understanding #CNPY2 could unlock new ways to slow or stop #tumor growth, improving patient care & reducing

🔬 New review from <a href="/OhioStateMedOnc/">Ohio State Medical Oncology</a> &amp; <a href="/OhioStatePIIO/">Pelotonia Institute for Immuno-Oncology</a> researchers explores #CNPY2 in #SolidTumors—its mechanisms, #biomarker potential, &amp; #therapeutic implications. Understanding #CNPY2 could unlock new ways to slow or stop #tumor growth, improving patient care &amp; reducing
Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

Honored to receive the Paul Calabresi K12 Award! Grateful for the support from my mentors at The James Ohio State Medical Oncology. and excited to continue advancing translational cancer research that makes a difference for patients!

Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

So glad to welcome the next CEO of @osuccc_james to Ohio State! Excited for your leadership and vision, looking forward to your guidance in the years ahead Kimryn Rathmell Dr. Kimryn Rathmell .

Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

Proud to be part of the GU oncology team at @osuwexmed Christian Rolfo ! OSU offers incredible support for new faculty, real work-life balance, and a welcoming, diverse community. Columbus, Dublin, and New Albany are beautiful places to raise a family—highly recommend joining us!

Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

Honored to be selected for the 2025 ASCO/AACR Methods in Clinical Cancer Research Workshop! Grateful for the support from Ohio State Medical Oncology The James and excited to keep moving our prostate cancer research forward!

Lingbin Meng (@lingbin_meng) 's Twitter Profile Photo

Thrilled to share my interview discussing our work with Dr. Yuanquan Yang on detecting molecular relapse after immunotherapy in urothelial and renal cell carcinoma! Dive into key insights: hmpgloballearningnetwork.com/site/jcp/video…

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

📺Watch Lingbin Meng discuss her latest research on using ctDNA to detect early molecular relapse in patients with urothelial carcinoma and renal cell carcinoma following immunotherapy hmpgloballearningnetwork.com/site/jcp/video…

📺Watch <a href="/lingbin_meng/">Lingbin Meng</a> discuss her latest research on using ctDNA to detect early molecular relapse in patients with urothelial carcinoma and renal cell carcinoma following immunotherapy hmpgloballearningnetwork.com/site/jcp/video…
Christian Rolfo (@christianrolfo) 's Twitter Profile Photo

Very happy to welcoming today Dr. Kimryn Rathmell to the Faculty Meeting, hearing about her vision for The James and discussing opportunities with the team. Honored to have her as member in our Division! Ohio State Medical Oncology

Very happy to welcoming today Dr. <a href="/KimrynRathmell/">Kimryn Rathmell</a>  to the Faculty Meeting, hearing about her vision for <a href="/OSUCCC_James/">The James</a>  and discussing opportunities with the team. Honored to have her as member in our Division! <a href="/OhioStateMedOnc/">Ohio State Medical Oncology</a>